<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124396">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01929473</url>
  </required_header>
  <id_info>
    <org_study_id>G-P001</org_study_id>
    <nct_id>NCT01929473</nct_id>
  </id_info>
  <brief_title>Seroepidemiological Study of Pertussis and Other Infectious Diseases</brief_title>
  <official_title>Seroepidemiological Study of Pertussis and Other Infectious Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gifu Prefecture Medical Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sanofi Pasteur S.A.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gifu Prefecture Medical Association</source>
  <oversight_info>
    <authority>Japan: Ministry of Health, Labor and Welfare</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Serum samples will be corrected twice from the same youth subjects with one year interval.

      Seroincidence of pertussis will be estimated by the elevation of Ig-G-PT in paired sera from
      an identical individual.

      The relationship between the incidence and the demographic data or medical history of the
      subjects will be discussed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>IgG</measure>
    <time_frame>0 day, 365 day (2 points)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Seroincidence of pertussis estimated by the elevation of Ig-G-PT in paired sera(0day, 365day).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of pertussis</measure>
    <time_frame>0 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibodies of varicella, mumps and rubella</measure>
    <time_frame>0 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection risk factors including family numbers, living space, with or without a cough patient in the surroundings, medical history and hospitalization</measure>
    <time_frame>365 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4500</enrollment>
  <condition>Pertussis Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Students of junior high school, high school or college
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Students of junior high school, high schools or college in Gifu prefecture

          -  Students who can have the second blood drawing one year later

          -  Students (and their parent when students are underage) whose written consent is
             obtainable.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naoki Kawai</last_name>
    <role>Study Chair</role>
    <affiliation>Gifu Prefecture Medial Association</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tsutomu Takeda</last_name>
    <phone>+81-92-738-0500</phone>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Gifu</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 30, 2013</lastchanged_date>
  <firstreceived_date>August 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pertussis infection</keyword>
  <keyword>Risk factors</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Whooping Cough</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
